1. ReportLinker Data
  2. Life Sciences
  3. Pharmaceutical
  4. Pharmaceutical Imports
  5. Import of Antisera and O…

Import of antisera and other blood fractions to Poland: Raise in 2016

United Nations Statistical Office announced that pharmaceutical import grew negligibly by 0.74 percent compared to the prior year. The indicator rose barely by 3 681 824 US Dollar, in contrast to the previous year when it fell by 13.16%. Poland saw a rise of 2 357.08% in pharmaceutical import during the last 23 years. Likewise, it has shown a growth at a 0.05% compound average annual growth rate over the 5 years with a modest overall increase since the start of observations. It averaged 197 780 321.04 US Dollar from 1994 to 2016 and it attained its all-time high of 576 406 976 US Dollar in 2014 and record low of 20 522 000 US Dollar in 1994.

Import of antisera and other blood fractions to Poland: Raise in 2016
Date US Dollar Variation
2016 504 241 280.00 0.74
2015 500 559 456.00 -13.16
2014 576 406 976.00 18.92
2013 484 712 640.00 25.15
2012 387 312 256.00 -1.31
2011 392 457 920.00 41.96
2010 276 451 072.00 1.06
2009 273 553 536.00 -7.42
2008 295 491 680.00 56.39
2007 188 949 072.00 66.32

Related Statistics

Pharmaceutical Imports in other Countries

Main Pharmaceutical Indicators

  • Pharmaceutical Imports

  • Pharmaceutical Exports

  • Medicine Use

    Use of medicines, usually meadured in in defined daily dosis (DDD) per day. The DDD consists of the assumed average maintenance dose per day for a drug used for its main indication in adults. Based on: World Health Organization.

  • Pharmaceutical Production

    Manufacture of basic pharmaceutical products and pharmaceutical preparations in million units of national currency or in volume index of production.

  • Pharmacist Density

  • Spending On Medicines

    Measures total value of spending on prescription medicines and insulins by retail pharmacies, hospitals, and other institutional pharmacies at invoice prices.

  • Re-Imbursed Pharmaceutical

    Share of re-imbursed medication in the pharmaceutical market, usually expressed in percentage of medication sales or in value of reimbursements (thousands or millions of national currency). It can be measured separately for generic medication and brand-name medication, or for the whole market. Based on: Organisation for Economic Co-operation and Development.

  • Pharmaceutical Revenue

    Revenue of pharmaceutical industry. The latter is comprised of companies engaged in researching, developing, manufacturing and distributing drugs for human or veterinary use. Based on: United States Department of Commerce.

  • Drug Store Retail Sales